3 hot shares to buy after today’s gains?

An unexpected share price movement could signal time to buy.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

One of the first things I do each morning is look to see which shares have risen and fallen the most when the markets opened. I know, it’s sad, but it can throw up unexpected possibilities for further research. Here’s a look at three of today’s winners.

Soaring pharmaceutical

Indivior (LSE: INDV) shares are up 15% to 345p after the company announced a positive result from phase 3 clinical trials of its RBP-6000 buprenorphine drug candidate for treating people addicted to opioids. The drug, which the firm described as possibly life-transforming, should hopefully now get the nod from the US Food and Drug Administration for further trials — and Indivior suggests it could be on the market as early as Q4 2017.

With the shares at record highs, have investors missed the boat? I don’t think so. We’re still only looking at a P/E multiple of 16. And while that’s a little above the FTSE 100‘s long-term average, I think it’s low for a pharmaceuticals researcher with such a promising prospect in its hands — and Indivior is nicely profitable, unlike some smaller researchers who are burning cash.

Misuse of drugs like heroin, morphine and prescription painkillers is being increasingly seen as a problem that needs to be addressed, and if this stuff fulfils its early hopes it could end up making Indivior shares look super-cheap today.

Profit from housing?

If housebuilders are in the dumps, that shouldn’t affect estate agents and property service companies, should it? That’s what investors in Savills (LSE: SVS) are presumably thinking, as the shares have put on 7% today to 748p. Savills shares were hit hard by Brexit fallout, but with today’s rise they’ve recovered a good bit of the loss and are now only 4% down since the day.

The latest boost came from an upgrade by Citigroup, from neutral to buy, based on Savills’ recent upbeat first-half figures. I agree. Savills only gets about 10% of its annual turnover from the EU, so there seems to be little Brexit danger, and with the shares having slipped over the past year they’re now valued at under 12 times forecast earnings, with dividend yields approaching 4%.

Net debt is low and Savills’ full-year expectations remain unchanged, so those forecasts should be close to the mark. The shares look cheap to me.

Strength in defence

The aerospace and defence sector has faced a few years of pressure, and that’s helped push Cobham (LSE: COB) shares down 43% since February 2015, including a big drop in April after the firm issued a profit warning. But today’s news of the arrival of a new chief executive in the shape of Laird boss David Lockwood, to replace the incumbent Bob Murphy, has cheered investors — and the share price is up 3.5% to 166p.

I’ve always been fairly bullish about the long-term prospects for the sector, though I think Cobham has needed a bit of a kick in the pants to shake it up for a while. This new appointment could be what the doctor ordered, and I wouldn’t be surprised to see a few radical changes when Mr Lockwood takes the helm — such transitions are often a trigger for a clean review of a business and the shedding of unnecessary costs.

We could see more hardship and perhaps a bit of belt-tightening before growth returns, but I’m cautiously optimistic.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »